Palliative physician supports neuraxial analgesia for cancer pain

10/23/2012 | Medscape (free registration)

Neuraxial analgesia is an effective palliative care option for cancer patients with refractory pain or opioid toxicity, and it can be continued after discharge, according to Dr. Aynharan Sinnarajah, an intensive palliative care physician from Alberta, Canada. He told a palliative care conference that fentanyl and methadone are commonly used instead of first-line opioids and that patients often are on their third or fourth opioid drug before neuraxial analgesia is considered.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ